It was recently revealed by the firm Genzyme Corp, which is the Cambridge segment of the French firm Sanofi, that their drug Fabrazyme has been approved by the FDA for starting production again. The firm recently said that this new drug, which is meant for the cure of Fabry disease, has been approved for production by the Food and Drug Administration in the United States.

The chief executive officer of Myriad Genetics Inc has said that the lab tests to pin point the tumour drug. The shares of the French drug maker fell, Sanofi on Friday due to a mishap. The lead drug in its research program failed in the last few stages of clinical research.

The French drug maker, Sanofi-Aventis SA, which made a hostile bid for Genzyme Corp., has extended the deadline to 21 January, for the U. S. shareholders of the biotechnology company to tender their stock.

Seeking to inflate growth potential and lower its dependence on blockbuster products, Sanofi-Aventis S. A. is in a positive discussion with an impending partner to penetrate the Japanese generic drug market.

The European Union's drug regulator down played claims by recent studies that suggested a possible risk with Sanofi-Aventis's widely-used diabetes drug, Lantus and cancer.

The booster shot of meningitis vaccine for children is set to resume beginning in July due to increased production by vaccine maker Sanofi-Pasteur. This will end the 18 month suspension of these shots which was put in place due to a Merck & Co. Inc. manufacturing shortage.

U. S. health regulators said they are investigating the effectiveness of the popular blood thinner Plavix which is the second-best-selling drug in the world, in some patients.